Heart failure drug use tracked in 13,660 remote monitoring patients
NCT ID NCT07022379
First seen Mar 29, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This study examined how often adults with chronic heart failure were prescribed SGLT2 inhibitors (a type of medication) when they joined a nationwide remote monitoring program in France between 2021 and 2024. Researchers looked at trends over time and factors like patient characteristics and healthcare settings that influenced prescribing. No new treatments were given—the study simply observed existing prescription patterns in routine care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NP Medical
Bordeaux, 33000, France
Conditions
Explore the condition pages connected to this study.